EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone



Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone



Cancer Treatment Reports 68(5): 733-738



We have utilized a human tumor cloning system to compare the antitumor activity of trimetrexate ( TMQ ), a new dihydrofolate reductase inhibitor, and ametantrone , a new anthracenedione, with that of analogs already in clinical trial (methotrexate and mitoxantrone). Sixty-nine of 136 tumors plated for the TMQ study and 84 of 228 tumors plated for the ametantrone study were evaluable for drug-sensitivity assays. The overall in vitro response rates (defined as a less than or equal to 50% survival of tumor colony-forming units) for TMQ were 20% and 23% at 0.1 and 1 microgram/ml, respectively; for ametantrone they were 13%, 21%, and 26% at 0.1, 1, and 10 micrograms/ml, respectively. The overall in vitro activity for both new compounds was similar to that of their clinically used analogs, but TMQ was active in eight of 47 methotrexate-resistant specimens and ametantrone in nine of 62 mitoxantrone-resistant specimens. A comparison of these in vitro results with the results of phase II clinical trials with both drugs should allow an evaluation of the utility of the human tumor cloning system for predicting clinical antitumor activity of analogs of currently available antineoplastic agents.

(PDF emailed within 1 workday: $29.90)

Accession: 006875774

Download citation: RISBibTeXText

PMID: 6233003



Related references

Activity of mitoxantrone in a human tumor cloning system. Cancer Research 41(5): 1853-1855, 1981

Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system. Investigational New Drugs 1(2): 139-144, 1983

Use of the human tumor cloning system to evaluate the aerobic cyto toxic activity of misonidazole. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 233, 1981

Methotrexate analogs 26. inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogs containing a basic amino acid side chain. Journal of Medicinal Chemistry 29(5): 655-660, 1986

In vitro comparison of vinzolidine and vinblastine a model for methods of evaluation of analogs in a human tumor cloning system. Cancer Research 45(12 PART 1): 6286-6289, 1985

Methotrexate analogs 18. enhancement of the anti tumor effect of methotrexate and 3' 5' di chloro methotrexate by the use of lipid soluble di esters. Journal of Medicinal Chemistry 26(10): 1448-1452, 1983

Methotrexate analogs part 7 synthesis of 2 higher homologues and a positional isomer of methotrexate di ethyl ester as potential anti tumor agents. Journal of Heterocyclic Chemistry 13(4): 727-732, 1976

Methotrexate analogs 23. synthesis di hydro folate reductase affinity cyto toxicity and in vivo anti tumor activity of some putative degradation products of methotrexate poly l lysine conjugates. Journal of Medicinal Chemistry 27(7): 888-893, 1984

Methotrexate analogs 27. dual inhibition of dihydrofolate reductase and folylpolyglutamate synthetase by methotrexate and aminopterin analogs with a gamma phosphonate group in the side chain. Biochemical Pharmacology 35(19): 3327-3334, 1986

New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice. Cancer Treatment Reports 69(5): 551-553, 1985

Methotrexate analogs part 4 7 methyl derivatives of methotrexate and di chloro methotrexate a new synthesis and some biological studies. Journal of Medicinal Chemistry 17(12): 1308-1311, 1974

Methotrexate analogs part 2 a facile method of preparation of lipophilic derivatives of methotrexate and 3 5 di chloro methotrexate by direct esterification. Journal of Medicinal Chemistry 16(10): 1190-1193, 1973

Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil with methotrexate mitoxantrone in advanced carcinoma of the breast. British Journal of Cancer 81(2): 316-322, Sept, 1999

Reduction of size of tumor colony forming units as a measure of drug effectiveness in the human tumor cloning system. Stem Cells (Basel) 1(4-5): 306-307, 1981